Announcements Trials
Browse Landscape

Phase

Phase 1 4

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 246Lymphoid 127Other hematologic neoplasm 66Thoracic 23Other solid neoplasm 16Sarcoma 14Genitourinary 14Myeloid 13Head & Neck 13Gastrointestinal 13Dermatologic 12CNS 11Gynecologic 8Breast 8Tumor-Agnostic 4Endocrine 4Classical hematology 3Other neoplasm 1

Conditions

Neoplasms 3Neoplasm Metastasis 1

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Bortezomib × Tumor-Agnostic × Clear all
NCT00895687 2015-07-13

Study of Erlotinib in Combination With Bortezomib

M.D. Anderson Cancer Center

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT00091117 2013-12-16

Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction

National Cancer Institute (NCI)

Phase 1 Completed
80 enrolled
Tumor-Agnostic

Neoplasms

NCT00298779 2008-06-06

Open-Label Study to Assess the Effect of Omeprazole on the Pharmacokinetics of VELCADE in Patients With Either Advanced Solid Tumors or Non-Hodgkin's Lymphoma.

Millennium Pharmaceuticals, Inc.

Phase 1 Completed
20 enrolled
Tumor-Agnostic

Neoplasms

NCT00129207 2008-02-11

Ketoconazole Administration: How it is Affected by the Body and Broken Down and How it Acts on the Body When Used With Velcade

Millennium Pharmaceuticals, Inc.

Phase 1 Completed
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡